ArticleLife metabolism2025

Development of cyclopeptide inhibitors specifically disrupting FXR-coactivator interaction in the intestine as a novel therapeutic strategy for MASH.

Yazhou Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.